Causes of infectious scleritis

Article

Fungus and microbial infection are the most common causes of infectious scleritis, according to study conclusions published in the February issue of Eye.

Fungus and microbial infection are the most common causes of infectious scleritis, according to study conclusions published in the February issue of Eye.

Vandana Jain, of the Aditya Jyot Eye Hospital, Mumbai, India, and colleagues conducted a retrospective chart review of all patients admitted to an Indian hospital with infectious scleritis between January 2000 and February 2005 (n=21) and then assessed factors including patient age, disease pathogenesis, clinical presentation, treatment and outcome.

The most common factors predisposing the patients to scleritis were previous surgery for cataract (n=6) or pterygium (n=5). In eight eyes, the scleritis was caused by fungus (most usually nocardia [n=5] or P. aeruginosa [n=2]), either as an isolated factor (n=5) or as a mixed infection (n=3). Scleritis was accompanied by corneal infiltration in seven eyes; multifocal scleral abscess and endophthalmitis each occurred in three eyes. To treat the condition, 14 eyes underwent surgical debridement and four eyes were eviscerated. During treatment, five eyes suffered either serous retinal or choroidal detachment, and five had progression of cataract. Visual acuity ≥20/200 was preserved in seven eyes.

Although the disease pathogenesis was similar in all cases, and the outcomes poor, the researchers concluded that fungi were the most common cause of infectious scleritis.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.